"We want to provide our biologics customers with tailor-made packaging solutions that they can be sure meet their specific requirements 100 percent," says Stefan Verheyden, Global Vice President of the Gerresheimer Biological Solutions Team.
Biopharmaceutical drugs are usually administered parenterally for the treatment of rheumatism, diabetes or cancer, for example. They differ from conventional drugs in their molecular structure. Gerresheimer has developed a complete package of products and services for biologics and biosimilars. This includes an innovative product portfolio of injection vials and special syringes as well as cartridges, drug delivery systems and other products which meet the specific requirements of this continuously growing market.
Many small to medium-sized customers active in the early stages of research and development typically require smaller sample quantities of up to 10,000 Gx RTF vials. Gerresheimer stocks these Gx RTF vials, as well as Gx RTF syringes, for customers to incorporate into their stability, testing and early clinical studies. Standard sizes such as 2R, 6R, 10R and 20R vials in trays with EU blowback are always available for this purpose. This means that the most used container formats for biopharmaceutical development are kept in stock, enabling customers to respond quickly to urgent market requirements.
Clinical supply program is part of a wide range of services
In addition to its broad product range, Gerresheimer offers a wide variety of services, particularly for small and medium-sized biotech companies, including advice on the right primary packaging material for the relevant clinical phase, support with approval and regulatory processes, laboratory services and much more.
Gerresheimer is the global partner for pharmaceutics, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America, and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people’s health and well-being.
Gerresheimer AG
Klaus-Bungert-Straße 4
40468 Düsseldorf
Telefon: +49 (211) 6181-00
Telefax: +49 (211) 6181-295
http://www.gerresheimer.de
Senior Manager Group Communication
Telefon: +49 (211) 6181-246
Fax: +49 (211) 6181-241
E-Mail: m.stolzenwald@gerresheimer.com